Host Craig Beavers sits down with Lorenz van der Linden, a Belgian pharmacist, to dive deep into 2 groundbreaking trials from the European Society of Cardiology (ESC) 2025 Congress.

administrator
Related Articles
Patritumab Deruxtecan Meets Primary End Point in ICARUS-BREAST01…
- September 9, 2025